{"DataElement":{"publicId":"2963486","version":"1","preferredName":"PSA Velocity Increase Monthly Rate","preferredDefinition":"Number to represent the calculated result of the monthly rate of increase in PSA (Prostate Specific Antigen) levels in succeeding PSA tests, expressed as ng/mL per month.","longName":"PSA_VEL_INC_MON_RT","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2963480","version":"1","preferredName":"PSA Velocity Rate","preferredDefinition":"A type of PSA assay which compares changes in PSA levels over time. A sharp rise in the PSA level raises the suspicion of cancer. (from Cancer Information Service)_A measurement of degree, speed, or frequency relative to time. (NCI)","longName":"PSA_VEL_RT","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2963478","version":"1","preferredName":"PSA Velocity","preferredDefinition":"A type of PSA assay which compares changes in PSA levels over time. A sharp rise in the PSA level raises the suspicion of cancer. (from Cancer Information Service)","longName":"C20119","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PSA Velocity","conceptCode":"C20119","definition":"A type of PSA assay which compares changes in PSA levels over time. A sharp rise in the PSA level raises the suspicion of cancer. (from Cancer Information Service)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7922C244-4ADC-DA02-E040-BB89AD436C14","latestVersionIndicator":"Yes","beginDate":"2009-11-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-24","modifiedBy":"ONEDATA","dateModified":"2009-11-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2682301","version":"1","preferredName":"Rate","preferredDefinition":"A measurement of degree, speed, or frequency relative to time. (NCI)","longName":"C25636","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rate","conceptCode":"C25636","definition":"A measurement of degree, speed, or frequency relative to time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A2E37B1-2019-1927-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-09-15","modifiedBy":"ONEDATA","dateModified":"2007-09-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435013","version":"1","preferredName":"Biological Process","preferredDefinition":"An activity that occurs between organisms or that occurs within an organism and involves the function, or modification of function by external factors, of biologic molecules, biologic complexes, subcellular components, cells, tissues, organs, or organ systems.","longName":"C17828 ","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AABF-C6A4-2728-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7922C244-4AEA-DA02-E040-BB89AD436C14","latestVersionIndicator":"Yes","beginDate":"2009-11-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-24","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2963475","version":"1","preferredName":"PSA Increase Monthly Rate","preferredDefinition":"Alternate isoforms of the single-chain 261-aa 30-kD Kallikrein 3 (Prostate Specific Antigen) glycoprotein precursor are encoded by human KLK3 Gene (Kallikrein Family). Frameshifted isoform 2 has a shorter distinct C-terminus. A serine protease in seminal plasma, PSA may function in liquefaction of seminal coagulum by (preferential Tyr-X) cleavage of seminal vesicle protein. Kallikrein proteases have diverse functions. Mounting evidence implicates kallikreins in carcinogenesis; some have potential as cancer biomarkers. The serum level of PSA is useful in diagnosis and monitoring of prostatic carcinoma. (from LocusLink, Swiss-Prot, OMIM, and NCI)_A process of becoming larger, more numerous, more important, or more likely._The property possessed by a line or surface that departs from the horizontal; the tangent of the angle it forms with the positive X axis._Every month._A measurement of degree, speed, or frequency relative to time. (NCI)","longName":"PSA_INC_MON_RT","context":"CCR","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"ng/ml","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2435013","version":"1","preferredName":"Biological Process","preferredDefinition":"An activity that occurs between organisms or that occurs within an organism and involves the function, or modification of function by external factors, of biologic molecules, biologic complexes, subcellular components, cells, tissues, organs, or organ systems.","longName":"C17828 ","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AABF-C6A4-2728-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2963484","version":"1","preferredName":"PSA Increase Monthly Rate","preferredDefinition":"Alternate isoforms of the single-chain 261-aa 30-kD Kallikrein 3 (Prostate Specific Antigen) glycoprotein precursor are encoded by human KLK3 Gene (Kallikrein Family). Frameshifted isoform 2 has a shorter distinct C-terminus. A serine protease in seminal plasma, PSA may function in liquefaction of seminal coagulum by (preferential Tyr-X) cleavage of seminal vesicle protein. Kallikrein proteases have diverse functions. Mounting evidence implicates kallikreins in carcinogenesis; some have potential as cancer biomarkers. The serum level of PSA is useful in diagnosis and monitoring of prostatic carcinoma. (from LocusLink, Swiss-Prot, OMIM, and NCI):Increase; a process of becoming larger or more numerous or more important.:Every month.:A measurement of degree, speed, or frequency relative to time. (NCI)","longName":"C17525:C25533:C64498:C25636","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate-Specific Antigen","conceptCode":"C17525","definition":"Prostate-specific antigen (261 aa, ~29 kDa) is encoded by the human KLK3 gene. This protein plays a role in both proteolysis and seminal fluid liquefaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Increase","conceptCode":"C25533","definition":"A process of becoming larger, more numerous, more important, or more likely.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Monthly","conceptCode":"C64498","definition":"Every month.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Rate","conceptCode":"C25636","definition":"A measurement of degree, speed, or frequency relative to time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7922C244-4B2B-DA02-E040-BB89AD436C14","latestVersionIndicator":"Yes","beginDate":"2009-11-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-24","modifiedBy":"ONEDATA","dateModified":"2009-11-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7921FAF2-CF48-B60C-E040-BB89AD4322B9","latestVersionIndicator":"Yes","beginDate":"2009-11-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-24","modifiedBy":"REEVESD","dateModified":"2009-11-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PSA Velocity","type":"Preferred Question Text","description":"PSA Velocity","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7922C244-4B41-DA02-E040-BB89AD436C14","latestVersionIndicator":"Yes","beginDate":"2009-11-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-24","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}